ClinicalTrials.Veeva

Menu
A

Allergy and Asthma Clinical Research | Walnut Creek, CA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Ligelizumab
azelastine hydrochloride
fluticasone propionate
Lanadelumab
azelastineHcl
azelastine Hcl
Indacaterol
Omalizumab
NOC-110
Remibrutinib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 25 total trials
Locations recently updated

A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma

The primary objective of this study is to describe the efficacy of rocatinlimab in reducing asthma exacerbations.

Enrolling
Asthma
Drug: Placebo
Drug: Rocatinlimab

The main aim of this study is to evaluate the PK, safety, tolerability and immunogenicity of subcutaneous (SC) administration of TAK-881 in adult and...

Enrolling
Primary Immunodeficiency Diseases (PID)
Biological: TAK-881
Biological: HYQVIA
Recently updated

This is an extension study to evaluate the long-term safety and efficacy of ligelizumab in participants who have completed a ligelizumab Phase III st...

Active, not recruiting
Food Allergy
Drug: Ligelizumab 120 mg
Drug: Ligelizumab 240 mg

A study to evaluate the safety, efficacy and tolerability of remibrutinib at three doses versus placebo in adult participants who have a confirmed al...

Enrolling
Allergy, Peanut
Drug: placebo
Drug: remibrutinib

This is a phase 2b, randomized, double-blind, placebo-controlled study investigating the efficacy, safety, and tolerability of Taplucainium Inhalatio...

Enrolling
Refractory or Unexplained Chronic Cough
Drug: NOC-110
Other: Placebo

Trial sponsors

Shire logo
Meda Pharmaceuticals logo
Novartis logo
Takeda logo
A
A
Amgen logo
CSL Behring logo
Genentech logo
N

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems